Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Two Years after Pandemic Influenza A/2009/H1N1: What Have We Learned?

Two Years after Pandemic Influenza A/2009/H1N1: What Have We Learned? Two Years after Pandemic Influenza A/2009/H1N1: What Have We Learned? Vincent C. C. Cheng a , b , Kelvin K. W. To a , c , Herman Tse a , c , Ivan F. N. Hung c , d and Kwok-Yung Yuen a , c a Department of Microbiology, Queen Mary Hospital, Hong Kong Special Administrative Region, China b Infection Control Team, Queen Mary Hospital, Hong Kong Special Administrative Region, China c State Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, The University of Hong Kong, Hong Kong Special Administrative Region, China d Department of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China SUMMARY Summary: The world had been anticipating another influenza pandemic since the last one in 1968. The pandemic influenza A H1N1 2009 virus (A/2009/H1N1) finally arrived, causing the first pandemic influenza of the new millennium, which has affected over 214 countries and caused over 18,449 deaths. Because of the persistent threat from the A/H5N1 virus since 1997 and the outbreak of the severe acute respiratory syndrome (SARS) coronavirus in 2003, medical and scientific communities have been more prepared in mindset and infrastructure. This preparedness has allowed for rapid and effective research on the epidemiological, clinical, pathological, immunological, virological, and other basic scientific aspects of the disease, with impacts on its control. A PubMed search using the keywords “pandemic influenza virus H1N1 2009” yielded over 2,500 publications, which markedly exceeded the number published on previous pandemics. Only representative works with relevance to clinical microbiology and infectious diseases are reviewed in this article. A significant increase in the understanding of this virus and the disease within such a short amount of time has allowed for the timely development of diagnostic tests, treatments, and preventive measures. These findings could prove useful for future randomized controlled clinical trials and the epidemiological control of future pandemics. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Clinical Microbiology Reviews American Society For Microbiology

Two Years after Pandemic Influenza A/2009/H1N1: What Have We Learned?

Two Years after Pandemic Influenza A/2009/H1N1: What Have We Learned?

Clinical Microbiology Reviews , Volume 25 (2): 223 – Apr 1, 2012

Abstract

Two Years after Pandemic Influenza A/2009/H1N1: What Have We Learned? Vincent C. C. Cheng a , b , Kelvin K. W. To a , c , Herman Tse a , c , Ivan F. N. Hung c , d and Kwok-Yung Yuen a , c a Department of Microbiology, Queen Mary Hospital, Hong Kong Special Administrative Region, China b Infection Control Team, Queen Mary Hospital, Hong Kong Special Administrative Region, China c State Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, The University of Hong Kong, Hong Kong Special Administrative Region, China d Department of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China SUMMARY Summary: The world had been anticipating another influenza pandemic since the last one in 1968. The pandemic influenza A H1N1 2009 virus (A/2009/H1N1) finally arrived, causing the first pandemic influenza of the new millennium, which has affected over 214 countries and caused over 18,449 deaths. Because of the persistent threat from the A/H5N1 virus since 1997 and the outbreak of the severe acute respiratory syndrome (SARS) coronavirus in 2003, medical and scientific communities have been more prepared in mindset and infrastructure. This preparedness has allowed for rapid and effective research on the epidemiological, clinical, pathological, immunological, virological, and other basic scientific aspects of the disease, with impacts on its control. A PubMed search using the keywords “pandemic influenza virus H1N1 2009” yielded over 2,500 publications, which markedly exceeded the number published on previous pandemics. Only representative works with relevance to clinical microbiology and infectious diseases are reviewed in this article. A significant increase in the understanding of this virus and the disease within such a short amount of time has allowed for the timely development of diagnostic tests, treatments, and preventive measures. These findings could prove useful for future randomized controlled clinical trials and the epidemiological control of future pandemics.

Loading next page...
 
/lp/american-society-for-microbiology/two-years-after-pandemic-influenza-a-2009-h1n1-what-have-we-learned-HRyp4Xz6GW

References (643)

Publisher
American Society For Microbiology
Copyright
Copyright © 2012 by the American society for Microbiology.
ISSN
0893-8512
eISSN
1098-6618
DOI
10.1128/CMR.05012-11
pmid
22491771
Publisher site
See Article on Publisher Site

Abstract

Two Years after Pandemic Influenza A/2009/H1N1: What Have We Learned? Vincent C. C. Cheng a , b , Kelvin K. W. To a , c , Herman Tse a , c , Ivan F. N. Hung c , d and Kwok-Yung Yuen a , c a Department of Microbiology, Queen Mary Hospital, Hong Kong Special Administrative Region, China b Infection Control Team, Queen Mary Hospital, Hong Kong Special Administrative Region, China c State Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, The University of Hong Kong, Hong Kong Special Administrative Region, China d Department of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China SUMMARY Summary: The world had been anticipating another influenza pandemic since the last one in 1968. The pandemic influenza A H1N1 2009 virus (A/2009/H1N1) finally arrived, causing the first pandemic influenza of the new millennium, which has affected over 214 countries and caused over 18,449 deaths. Because of the persistent threat from the A/H5N1 virus since 1997 and the outbreak of the severe acute respiratory syndrome (SARS) coronavirus in 2003, medical and scientific communities have been more prepared in mindset and infrastructure. This preparedness has allowed for rapid and effective research on the epidemiological, clinical, pathological, immunological, virological, and other basic scientific aspects of the disease, with impacts on its control. A PubMed search using the keywords “pandemic influenza virus H1N1 2009” yielded over 2,500 publications, which markedly exceeded the number published on previous pandemics. Only representative works with relevance to clinical microbiology and infectious diseases are reviewed in this article. A significant increase in the understanding of this virus and the disease within such a short amount of time has allowed for the timely development of diagnostic tests, treatments, and preventive measures. These findings could prove useful for future randomized controlled clinical trials and the epidemiological control of future pandemics.

Journal

Clinical Microbiology ReviewsAmerican Society For Microbiology

Published: Apr 1, 2012

There are no references for this article.